Nuvig Therapeutics raised $161 million in a Series B funding round co-led by Sanofi Ventures and Blue Owl Healthcare Opportunities to support the clinical development of its novel immunomodulatory therapeutics.
Amount Raised
$161 Million
Round Type
Series B
Menlo ParkBiotechnologyHealth CareTherapeuticsresearchInvestors
Description
Nuvig Therapeutics announced the closing of a $161 million Series B financing to advance its novel immunomodulatory therapeutics for patients with inflammatory autoimmune diseases. The financing will support clinical proof-of-concept studies for lead candidate NVG-2089 and the company's preclinical pipeline.
Quick answer
Nuvig Therapeutics raised $161 Million in a Series B round, dated December 5, 2024. Investors: Global BioAccess Fund, Mission BioCapital, Leaps By Bayer, Lotte Holdings, Alexandria Venture Investments, Abrdn Inc., Novo Holdings A/S and Platanus. Nuvig Therapeutics is based in Menlo Park, California, United States.
- How much did Nuvig Therapeutics raise?
- Nuvig Therapeutics raised $161 Million in a Series B round on December 5, 2024.
- Who invested in Nuvig Therapeutics?
- Global BioAccess Fund, Mission BioCapital, Leaps By Bayer, Lotte Holdings, Alexandria Venture Investments, Abrdn Inc., Novo Holdings A/S and Platanus are named as investors in this round.
- What does Nuvig Therapeutics do?
- Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the..
- Where is Nuvig Therapeutics based and how big is it?
- Nuvig Therapeutics is based in Menlo Park, California, United States. Fundz records about 26 employees.
- Who are the decision-makers at Nuvig Therapeutics?
- Fundz holds 2 contacts at Nuvig Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and research around the same time
Companies in the same sectors as Nuvig Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Aarvik Therapeutics raised $1.2M (Seed) on November 4, 2024.
- Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.
- VisiRose raised $3M (Seed) on January 16, 2025.
- Phio Pharmaceuticals raised $208K (Seed) on January 15, 2025.
- Phio Pharmaceuticals raised $266K (Seed) on January 14, 2025.
- First Ascent Biomedical raised $6M (Angel) on January 13, 2025.
Who to call at Nuvig Therapeutics, and when
A new round usually means Nuvig Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nuvig Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nuvig Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nuvig Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nuvig Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNuvig Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.